Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

Annals of Oncology - Tập 31 - Trang 1040-1045 - 2020
M. Montopoli1,2, S. Zumerle2,3, R. Vettor3, M. Rugge3,4, M. Zorzi4, C.V. Catapano5, G.M. Carbone5, A. Cavalli6, F. Pagano2, E. Ragazzi1, T. Prayer-Galetti7, A. Alimonti2,3,5,8
1Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy
2VIMM – Veneto Institute of Molecular Medicine, Fondazione per la Ricerca Biomedica Avanzata, Padova, Italy
3Department of Medicine, Università degli Studi Di Padova, Padova, Italy
4Veneto Tumour Registry, Azienda Zero, Padova, Italy
5Institute of Oncology Research, Oncology Institute of Southern Switzerland, Università della Svizzera Italiana, Bellinzona, Switzerland
6Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland
7Department of Oncological and Gastroenterological Sciences – Urology Unit, Azienda Ospedaliera di Padova, Padova, Italy
8Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland

Tài liệu tham khảo

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Bugge, 2009, Type II transmembrane serine proteases, J Biol Chem, 284, 23177, 10.1074/jbc.R109.021006 Choi, 2009, Type II transmembrane serine proteases in cancer and viral infections, Trends Mol Med, 15, 303, 10.1016/j.molmed.2009.05.003 Shin, 2017, Type II transmembrane serine proteases as potential target for anti-influenza drug discovery, Expert Opin Drug Discov, 12, 1139, 10.1080/17460441.2017.1372417 Glowacka, 2011, Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol, 85, 4122, 10.1128/JVI.02232-10 Iwata-Yoshikawa, 2019, TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection, J Virol, 93, e01815, 10.1128/JVI.01815-18 Matsuyama, 2010, Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2, J Virol, 84, 12658, 10.1128/JVI.01542-10 Shen, 2017, TMPRSS2: a potential target for treatment of influenza virus and coronavirus infections, Biochimie, 142, 1, 10.1016/j.biochi.2017.07.016 Shulla, 2011, A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry, J Virol, 85, 873, 10.1128/JVI.02062-10 Tarnow, 2014, TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice, J Virol, 88, 4744, 10.1128/JVI.03799-13 Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Matsuyama, 2020, Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells, Proc Natl Acad Sci U S A, 117, 7001, 10.1073/pnas.2002589117 Lucas, 2014, The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis, Cancer Discov, 4, 1310, 10.1158/2159-8290.CD-13-1010 Lucas, 2008, The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma, J Pathol, 215, 118, 10.1002/path.2330 Mikkonen, 2010, Androgen receptor and androgen-dependent gene expression in lung, Mol Cell Endocrinol, 317, 14, 10.1016/j.mce.2009.12.022 Miettinen, 1985, Comparative analysis of two rates, Stat Med, 4, 213, 10.1002/sim.4780040211 Sheskin, 2004 Cai, 2020, Sex difference and smoking predisposition in patients with COVID-19, Lancet Respir Med, 8, e20, 10.1016/S2213-2600(20)30117-X Ferlay, 2018, Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018, Eur J Cancer, 103, 356, 10.1016/j.ejca.2018.07.005 Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 335, 10.1016/S1470-2045(20)30096-6 Lazzerini, 2020, COVID-19 in Italy: momentous decisions and many uncertainties, Lancet Glob Health, 8, e641, 10.1016/S2214-109X(20)30110-8 Remuzzi, 2020, COVID-19 and Italy: what next?, Lancet, 395, 1225, 10.1016/S0140-6736(20)30627-9 Drosten, 2003, Identification of a novel coronavirus in patients with severe acute respiratory syndrome, N Engl J Med, 348, 1967, 10.1056/NEJMoa030747 Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, N Engl J Med, 348, 1953, 10.1056/NEJMoa030781 Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N Engl J Med, 367, 1814, 10.1056/NEJMoa1211721 Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679 Shaw, 2016, The early effects of rapid androgen deprivation on human prostate cancer, Eur Urol, 70, 214, 10.1016/j.eururo.2015.10.042 Asangani, 2014, Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer, Nature, 510, 278, 10.1038/nature13229 Faivre, 2017, Exploitation of castration-resistant prostate cancer transcription factor dependencies by the novel bet inhibitor ABBV-075, Mol Cancer Res, 15, 35, 10.1158/1541-7786.MCR-16-0221 Ianculescu, 2012, Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells, J Biol Chem, 287, 4000, 10.1074/jbc.M111.300194 Gordon, 2010, CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation, Mol Endocrinol, 24, 2267, 10.1210/me.2010-0238 Shinde, 2019, Transcriptional reprogramming and inhibition of tumor-propagating stem-like cells by EC-8042 in ERG-positive prostate cancer, Eur Urol Oncol, 2, 415, 10.1016/j.euo.2018.08.024 Klein, 2016, Sex differences in immune responses, Nat Rev Immunol, 16, 626, 10.1038/nri.2016.90 Barnes, 2020, Targeting potential drivers of COVID-19: neutrophil extracellular traps, J Exp Med, 217, e20200652, 10.1084/jem.20200652 Arora, 2013, Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade, Cell, 155, 1309, 10.1016/j.cell.2013.11.012 Xu, 2018, Nuclear receptor ERRalpha and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer, Oncogene, 37, 6259, 10.1038/s41388-018-0409-7